To evaluate effect of dual T-cell depletion with anti-thymocyte globulin (ATG) and post-transplantation cyclophosphamide (PTCy) in peripheral blood haploHCT and report the impact of reducing the dose of ATG from 4.5 mg/kg to 2 mg/kg on post-transplantation complications
Latest Information Update: 13 Aug 2021
At a glance
- Drugs Antithymocyte globulin (Primary) ; Ciclosporin (Primary) ; Cyclophosphamide (Primary)
- Indications Graft-versus-host disease
- Focus Adverse reactions; Therapeutic Use
- 13 Aug 2021 New trial record